Radiopharm Theranostics (RADX) Enterprise Value (2024 - 2025)
Radiopharm Theranostics (RADX) reported Enterprise Value of -$11.9 million for Q2 2025, down 54.35% year-over-year from -$26.1 million in Q2 2024, and down 54.35% quarter-over-quarter from -$7.7 million in Q2 2024.
Radiopharm Theranostics (RADX) Enterprise Value (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has 2 years of Enterprise Value data on file, last reported at -$11.9 million in Q2 2025.
- Enterprise Value for Q2 2025 came in at -$11.9 million, down 54.35% year-over-year; the trailing twelve-month figure through Jun 2025 was -$11.9 million (down 54.35% YoY), and the FY2025 annual result was -$29.1 million, down 277.56% from the prior year.
- Enterprise Value fell to -$11.9 million in Q2 2025 per RADX's latest filing, from -$7.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$7.7 million in Q2 2024 and troughed at -$11.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Radiopharm Theranostics | 5.82 Bn | 5.81 Bn | - | -11.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -11.91 Mn |
| Jun 30, 2024 | -7.72 Mn |